Michigan’s adult obesity rate sits at approximately 35.1%, according to the CDC’s 2025 BRFSS data released in September 2026. That places the state among roughly 21 states at or above 35%. Demand of that scale has produced a crowded and uneven market, one that includes hospital systems, independent physician-led clinics, legacy non-surgical chains, and telehealth sellers built around discounted prescriptions.
This guide does not list Michigan clinics. It offers a clinician-grade framework that readers can apply to any clinic they are considering. The guide draws on three Michigan-specific evidence anchors:
- The 2025 BRFSS obesity data
- A University of Michigan study published in JAMA Network Open
- The 2026 coverage changes from the Healthy Michigan Plan and Blue Cross Blue Shield of Michigan
The goal is education, not a sales pitch.
What “Medical” Weight Loss Actually Means
A medical weight loss program requires more than access to a prescription. A program that earns the name includes four elements:
- Oversight from a physician or advanced-practice clinician
- Diagnostic baseline testing
- An individualized treatment plan
- Ongoing monitoring
These elements separate medical weight loss from two other models. Med spas often offer weight loss as an add-on service. Direct-to-consumer telehealth subscriptions often function mainly as prescription-dispensing services.
The distinction matters more in Michigan in 2026, as self-pay demand rises and access to medication becomes more complicated. The Obesity Medicine Association, The Obesity Society, and the Obesity Action Coalition addressed this in their 2026 joint clinical practice guideline. The guideline treats counseling before, during, and after treatment as the standard of care, not medication alone.
Credential Check: Verifying Who Is Actually Treating You
The American Board of Obesity Medicine (ABOM) offers a concrete credential that patients can verify publicly. To become an ABOM Diplomate, a physician must have:
- An unrestricted medical license
- A completed residency in the US or Canada
- ABMS or AOA board certification
- At least 60 CME credit hours in obesity medicine
Patients can ask any Michigan clinic whether its supervising physician is an ABOM Diplomate, then confirm the answer through ABOM’s public physician directory.
Physician Oversight vs. Prescriber-Only Models
In some clinics, a physician defines the treatment plan and monitors it over time. In others, oversight is nominal, such as a remote sign-off on a questionnaire. Ongoing physician involvement matters because dose adjustments, side-effect management, and long-term planning all depend on someone who knows the patient’s history.
The Research Case for Specialist-Led Care in Michigan
Researchers at Michigan Medicine studied patients who were paired with a board-certified obesity specialist in addition to their primary care provider. Published in JAMA Network Open, the study found that these patients lost meaningfully more weight than matched controls who received standard care.
The implication is clear: specialist oversight drives outcomes rather than serving as a formality. This is peer-reviewed evidence from within the state, not a generic national claim. For Michigan patients, ABOM certification is the most practical way to confirm this level of expertise before enrolling.
The Brick-and-Mortar Difference: Labs, Visits, and Clinical Infrastructure
A video call cannot replace physical infrastructure. An in-person clinic can draw baseline labs, take vitals, track body composition, and perform a physical assessment.
A legitimate intake should include three things:
- Baseline bloodwork
- A review of the patient’s medical history
- A documented rationale for the treatment plan
Approval based only on a questionnaire does not meet that standard.
Baseline Labs and Ongoing Monitoring
Baseline labs serve two purposes. They help with safety by flagging conditions that affect treatment decisions, and they help personalize the plan. Common panels cover metabolic, thyroid, and general health markers.
Follow-up labs matter just as much. Periodic testing lets clinicians adjust the plan over time, support nutrient balance, and help preserve muscle mass while a patient loses weight.
In-Person Visits and Cadence of Care
A defined visit schedule signals active clinical management. One-time telehealth check-ins do not. Patients can ask any clinic a simple question: “What does my follow-up schedule look like in month one, month six, and after a year?”
Red Flags: Low-Oversight and Compounded-Medication Risk
Telehealth-only sellers of compounded GLP-1 medications have grown quickly, and many compete mainly on price. FDA enforcement has increased in response:
- In September 2025, the agency sent more than 55 warning letters to online sellers of compounded GLP-1 products.
- Additional waves of 25 to 30 letters followed in early 2026.
- The FDA has logged more than 1,700 adverse event reports tied to compounded semaglutide and tirzepatide, and some of those events required hospitalization.
These figures show how widely oversight quality varies among sellers. Compounded medications fall into a different regulatory category than FDA-approved drugs, which makes prescriber oversight more important. This is a reason to choose a clinic that actively monitors patients, not a reason to avoid compounded medications outright.
Patients can use three red-flag questions:
- Is there a named, licensed physician?
- Is there an in-person or live clinical evaluation before a prescription is written?
- Is there any follow-up plan at all?
Michigan’s 2026 Insurance Shift and Why It Raises the Stakes
Two coverage changes have reshaped how Michigan residents pay for weight-loss care:
- Healthy Michigan Plan: Effective January 1, 2026, Michigan Medicaid restricts GLP-1 coverage for weight management to patients with a BMI of 40 or higher who meet strict step-therapy criteria.
- Blue Cross Blue Shield of Michigan and Blue Care Network: Weight-loss GLP-1 coverage ended for fully insured large groups on January 1, 2025.
As a result, more Michigan residents now pay out of pocket. That makes transparent pricing and a clear program structure more important. A clinic should be able to show its value beyond the prescription itself. Useful questions include:
- What does the program fee include?
- What happens if a patient does not meet insurance coverage criteria?
- Are all costs presented clearly before the patient commits?
The Maintenance Question: What Happens After the Medication
Weight regain after patients stop GLP-1 medications is well documented. A systematic review published in eClinicalMedicine (The Lancet) found that a substantial share of weight lost during treatment tends to return within about a year of stopping.
Many patients also stop treatment early. In a real-world Optum claims-database analysis, 55% of patients were still taking their GLP-1 at six months, and only 38% were still taking it at twelve months.
These findings point to a structural question rather than a promised result: does the clinic have a defined long-term maintenance phase, or does its model end at the prescription? Clinical bodies treat this as essential. The 2025 joint advisory from the OMA and its partners on nutritional priorities for GLP-1 therapy reflects the view that nutrition and maintenance are required parts of care, not optional extras.
A Practical Checklist for Evaluating Any Medical Weight Loss Clinic in Michigan
Patients can bring this checklist to a consultation:
- A named, licensed supervising physician
- ABOM certification or equivalent training in obesity medicine
- An in-person baseline evaluation and labs
- A defined follow-up schedule
- Transparent self-pay pricing, given the 2026 insurance changes
- An explicit maintenance plan that extends beyond the initial medication phase
- Clear answers about sourcing and oversight if the clinic offers compounded medications
A consultation should work as a two-way interview, not just an intake appointment.
The Standard to Hold Any Clinic To
A useful benchmark for good care comes from models built on decades of in-person, physician-led practice. Red Mountain is one example. Its model includes:
- More than 30 years of real-world patient outcomes
- Brick-and-mortar clinics staffed with in-person providers
- Physician-led oversight
- A structured long-term maintenance phase
In this model, medication is one tool among several, alongside nutrition strategy, monitoring, and ongoing support. Red Mountain does not currently operate a Michigan clinic. It is offered here only as a reference standard for comparison.
Conclusion: Choosing with Evidence, Not Convenience
With Michigan’s obesity rate near 35% and insurance coverage tightening in 2026, choosing a low-oversight clinic carries a higher cost than ever. Four pillars matter most:
- Verified physician credentials, such as ABOM certification
- In-person clinical infrastructure, including labs
- Transparent pricing in light of the Medicaid and BCBS changes
- A defined maintenance phase, supported by the regain and discontinuation data
This framework applies to any clinic a Michigan reader is considering. The University of Michigan study shows that specialist oversight makes a measurable difference. Informed patients ask better questions, and better questions lead to better long-term care.
Next Step: Bringing These Questions to a Consultation
The most useful next step is to gather information, not to commit. An initial consultation is the right setting to discuss physician credentials, lab requirements, pricing, and long-term maintenance planning in depth. If these questions sound familiar, a consult is usually the place to get clear answers.
Red Mountain may prescribe a compounded version of a GLP-1. Compounded GLP-1s contain semaglutide or tirzepatide. Compounded GLP-1s have not been approved by the FDA or reviewed by the FDA for safety, effectiveness, or quality. Compounded GLP-1s have not been demonstrated to the FDA to be safe or effective for weight loss. Compounded GLP-1s manufacturing processes have not been reviewed by the FDA. FDA-approved products containing semaglutide and tirzepatide are available. Ask your provider for more information.